ArticleClinical pharmacokinetics2025

TDM-Based Tailored Dosing of Durvalumab in Lung Cancer Patients: A Comprehensive Population Pharmacokinetic-Pharmacoeconomic Evaluation.

Fenna de Vries et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.